Pharmaceutical giant Pfizer announced on Monday it has agreed to buy Canadian drug developer Trillium Therapeutics in a deal valued at $2.26 billion to strengthen its arsenal of blood cancer therapies. According to the announcement, Pfizer will pay $18.50 for […]